This newspaper article reports on the findings of a study that compares prevalence and outcomes of minimally invasive laparoscopic prostate removal with the standard "open" surgical method. The findings, published in the Journal of Clinical Oncology provide a useful snapshot at a time when laparoscopic surgery is rapidly becoming popular.
The news article does a solid job of describing the findings in detail and providing comments from independent sources who help interpret them. The reader takes away the idea that laparoscopic surgeries, despite their increased popularity, appear to have significant potential harms.
But the article leaves some major questions unanswered.
First, the newspaper report does not mention costs. Robot-assisted procedures are inherently controversial because the equipment is so costly but the benefits unknown. By not mentioning costs of the surgery, the article strips the findings of context.
Second, the study itself looks at a very narrow question–it compares the two surgical approaches in a 65-plus population. But the analysis did not account for disease state, mortality, the side effects of surgery men are most likely to care about (impotence and incontinence), or even whether the laparoscopic procedures were robot-assisted. The possibility that selection bias colors the findings is obvious.
This is an important piece of research in the field. But given its limitations, it’s not clear that reporting on the findings to a large audience has much public value.
The story does not report how much the laparoscopic surgery costs, either directly or over time due to fewer complications or more treatments.
One assumes that robot-assisted surgeries are more expensive, though again the story should have specified. Given the possibility of economic self-interest by proponents of laparoscopic surgery, this information would have been very useful.
A daVinci machine reportedly costs over a million dollars, with signficant annual maintenance costs in addition.
The article does a thorough job of describing the findings by specifying the percentage of patients who had minor and more serious complications. It also compares days spent in the hospital.
However, the article reports a 27 percent reduction in risk of short-term complications and a 40 percent greater risk of scarring without indicating the underlying risks for either of these outcomes. See our primer on absolute versus relative risk statements.
The story explictly compares the harms of the two surgical approaches in terms of short-term complications and longer-term consequences.
The article is based on a retrospective study of outcomes in a large population, conducted by university researchers and published in a major peer-reviewed journal.
However, there have been no head-to-head randomized trials comparing open vs. laparoscopic prostatectomies. Since outcomes in observational studies are subject to selection bias, the article should have plainly indicated this.
The story does nothing to exaggerate the complications of prostatectomy or the success of the procedures studied.
The article uses as sources the study itself, the lead author, and two independent medical specialists. This is sufficient sourcing.
It is not known if any of the researchers had ties to interested parties such as device makers. The published abstract does not include this information.
The article, like the study upon which it is based, compares only two treatment options–miniminally invasive laparoscopic surgery and traditional "open" surgery to remove the prostate.
It would have been helpful, but not necessary, to place these two approaches in the context of the many choices men with prostate cancer face based on age, severity, co-morbidities, personal preference and other factors.
The story implies that laparoscopic prostatectomies are widely available, and in fact are done about a third of the time in the studied population.
But it would have been useful to state how difficult it is (or is not) to find a surgeon experienced with laparoscopic procedures.
The story plainly states that the procedure is increasingly common and widely advertised. It cites figures from the study that demonstrate the increase of use between 2003 and 2005.
It does not appear that a press release is associated with this journal article.
Systematic, Criteria-Driven
We’ve written about the hype of liquid biopsies for years (see link in comment below). And now this…. https://www.statnews.com/2022/01/12/medicare-shouldnt-cover-liquid-biopsies-early-cancer-detection/
Case counts still matter. “(There) are stories that may not be told adequately if only hospitalizations and deaths are emphasized.” @garyschwitzer interviewed by @dbauder of @AP. https://apnews.com/article/omicron-changing-news-outlets-covid-data-da9272f7c4c8a109c3bfb56bed9e9c76
My friend Gary @garyschwitzer wrote to his city council representative in a Minnesota town about a Viva Las Vegas event scheduled for January.
The response he got seems to perfectly capture where we are now.
https://www.healthnewsreview.org/2021/12/2021-ends-with-covid-craziness-in-sports-and-politics/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.